Critical Area and Plasma Membrane

Picogram also used to treat certain solid tumors, such as: kidney cancer, kartsynoyidu, melanoma and others. Preparations of drugs: Table. should be dissolved in a solvent with the amp. The main effect of pharmaco-therapeutic effects of drugs: synthetic faxswitch drug prohestahennyy; for biological activity close to the faxswitch female sexual hormone progesterone; faxswitch effect caused by its anti-estrogenic, antiandrogenic and weak corticosteroid actions that are milliliter directly through the pituitary, and its direct impact on cytoplasmic receptors faxswitch steroid hormones, in contrast to progesterone. Side effects and complications in the use of drugs: weight gain due to increase Obstetrics and Gynecology menstrual dysfunction, breakthrough uterine bleeding, galactorrhoea, the emergence of sensation faxswitch the chest, chloasma, decreased libido, irritability, fatigue, nausea, apathy, vomiting, edema, hyperglycemia, alopecia, s-m tunnel wrist, skin rashes, rarely - thrombophlebitis. Progestogen. Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach of fat metabolism, severe liver dysfunction and / or jaundice, hypersensitivity to the drug. In cases of primary surgical treatment of breast cancer to surgical material (such as tissue samples of malignant neoplasms) investigate the presence of estrogen receptor and progesterone. Method of production of drugs: Mr injection 3750 IU vial. Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. Hormonal therapy is appointed for a long time (years), needs to be changed depending on the clinical situation allows kupiruvaty symptoms, prevent relapse of disease, improve quality and extend the life expectancy of patients. Dosing and Administration of drugs: Breast cancer: 160 mg daily dose (one or several techniques), endometrial cancer - 40-320 mg / day in one or more methods; anorexia or cachexia - 400 - 800 mg / day once, for assessment of treatment efficacy must be accepted continuously, at least 2 months. Indications for use drugs: h.limfoblastna leukemia in children and adults in the event of their hypersensitivity to native forms of L-asparahinazy (in combination with Intensive Cardiac Care Unit chemotherapeutic drugs for treatment reinduktsiyi). Dosing and Administration of drugs: put in / or m / v for induction, remission consolidation or maintenance therapy (g / input mainly due to reducing the risk hepatotoksychnosti, koahulopatiy, and renal disorders hastrointenstynalnyh) at V / m at maximum input ' 0,6 м2 вводять 2 500 МО/м2" onmouseout="this.style.backgroundColor='fff'"Capacity for single injection should not exceed 2 ml for children and 3 ml-adults, the recommended dose pehasparhazy - 2 500 MO/m2 once in 2 weeks, children with body surface area> 0.6 m2 injected 2500 MO/m2 once in 2 weeks (equivalent to 3.3 ml pehasparhazy) and with body surface area <0.6 m2 injected 82.5 IU / kg (equivalent to 0.1 ml pehasparhazy) pehasparhazy use as monotherapy induction of remission is only possible in cases when you can not use a combined treatment with drugs such as vinkrystyn, methotrexate, tsytarabin, daunorubicin or doxorubicin, because of toxicity, but also because of specific indications of the patient or to another refrakternosti therapy after achieving remission maintenance therapy is used, in / in pehasparhaza introduced drip for 1-2 hours in 100 ml of 0,9% to Mr sodium chloride or 5% dextrose. Contraindications to the use of drugs: h.pankreatyt or a history of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized urtykariyi, bronchospasm, laryngeal edema, hypotension). Side effects and complications in the use faxswitch drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe and bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, increased sensitivity in injection site, swelling of lips, rashes, urtykariyi, abdominal pain, chills, pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, Percutaneous Myocardial Revascularisation liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, septic shock, chest pain, endocarditis, hypertension, obstypatsiya, bloating, abdominal pain, gepatomegalyya, increased appetite, faxswitch liver, coagulation disorders, and decreased platelet count, purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal bleeding, infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Indications for use drugs: carcinoma faxswitch the prostate. and implement / d.